Menu

Frederic JORIS

STEIN

En résumé

My Specific Competencies and Key Strengths:
Excellent organization, communication and leadership skills.
Result driven, customer oriented and follow-up minded.
Strive for continuous improvements and high quality.
Energize, influence and motivate others.
Take initiative, encourage and develop new ideas, simplicity driven and avoid bureaucracy.
Highly accountable and self discipline, especially where endurance and integrity is asked.
Team and business oriented and good coaching abilities.

Easy-going and quick integration in new and difficult environment, very good capabilities for learning and constant seek for new challenges, build relationship.

Good and complete process technical background, developed with the practice in different projects and countries, including construction activities, critical utilities (Purified Water and Compressed Air), room conditioning and infrastructure.

Mobile everywhere. Availability for travelling and new challenge.

Entreprises

  • Novartis Pharma Stein AG - Facilitator

    2010 - 2012 09/2010 – present Novartis Pharma Stein AG, Switzerland, Facilitator
    End to End operational responsibility within the PU Actives (Galenical processing up to packaging operations) with indirect responsibility up to 60 associates. Total sales value of ca 1.2 milliard for 2011.
    Major contributor to the ramp-up of a major product (Galenik and Packaging Operations), which involved doubling output from approx 400,000 packs per month to 1Mio Packs per month.
    Successful implementation as pilot of the 5S –Program in the packaging area (part of TPM initiatives), which is today taken as a reference in Stein.
    Productivity improvement of the 4 Eucreas Packaging Lines from 30 to 50& and pack per FTE from 20'000 to 45'000.

  • Novartis Grimsby Ltd - IQP Champion for Engineering (six sigma)

    2009 - 2010 02/2009 – 08/2010 Novartis Grimsby Ltd., U.K., IQP Champion – Engineering,
    Implementation of IQP methodology (six sigma) and development of OPEX model for Engineering Support Unit.
    Reduction of the engineering store inventory value of ca. ~1,0 Mio £ by identifying and removing obsolete items and implementation of a clear process to consider spares during the life cycle of an equipment.

  • Novartis Pharma AG - Project Manager

    RUEIL MALMAISON 2001 - 2009 06/2001-01/2002 Novartis Pharma Stein AG, Switzerland, Project Engineer
    Responsible for feasibility studies, plant design, installation and start-up of sterile pharmaceutical production facilities fulfilling FDA, EMEA as well as local health and other legal requirements. Deputy for Project Manager.

    01/2002-11/2002 Novartis Pharma AG, Switzerland, Project Engineer
    Project for the international product transfer.Responsible for conceptual and basic Engineering and preparation of business case and follow-up until April 2003.

    11/2002–06/2003 Novartis Pharma AG, Switzerland, Project Engineer
    Responsible for the conceptual and basic Engineering of the processing equipment and coordination of process engineering activities with external company Jacobs Engineering for the new solid dosage form (green field project)

    06/2003–06/2004 Novartis Pharma AG, Switzerland, Project Engineer
    Responsible for conceptual and basic Engineering of the BTD Pilot Plant, planned for the manufacturing of biopharmaceutical active ingredients for the clinical supply of phases I and II

    08/2004 –09/2005 Novartis Singapore Pharmaceutical Manufacturing, Singapore,
    Discipline Engineer, responsible for the conceptual, basic and detail design of the entire processing area, including processing equipment. Procurement of the processing equipment for the new solid dosage form facility. Total Investment Cost for Project 115 Mio USD. Leading the processing Engineering team composed of external resources (up to 4 FTEs)

    10/2005 -02/2009 Beijing Novartis Pharma, P.R. China, Project Manager Responsible for the overall project including Detail Engineering, Construction phase and commissioning/qualification of the extension of the Solid Dosage Form Facility. Direct responsibility of ca 20 FTEs. Total Investment Cost 24 Mio USD.

Formations

  • Ecole Polytechnique Fédérale (ETH) ETH (Zurich)

    Zurich 1993 - 1998 Ingénieur chimiste

    Chemical Engineering

Réseau

Annuaire des membres :